Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma

LONDON, April 12, 2013 /PRNewswire/ --

Markets showed broad gains as these continued their upward ascent. The new earnings season has started on a positive note and provided a good fillip to the stocks. Unemployment benefit data also showed decline, raising optimism about the pace of economic growth. Major indices like The Dow Jones Index and S&P500 are trading at all time high. Healthcare sector remained robust and our research team tracked major companies like Sequenom Inc. (NASDAQ: SQNM) and Peregrine Pharmaceuticals (NASDAQ: PPHM), which remained subdued. On the other hand, Inovio Pharmaceuticals Inc. (NYSE: INO) and Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) showed good gains. StockCall initiated free in-depth technical analysis on SQNM, PPHM, INO, and ONXX which are currently available upon sign up at

http://www.stockcall.com/research

Sequenom Inc. is trading above its long-term moving average price, indicating a bullish trend. It also closed its latest trading session at $4.08, same as its previous close. The stock traded below average volume of 2.34 million shares. Sequenom trades at beta of 0.07, implying very low volatility. However, the stock declined 9.33 percent this year while it gained 5.15 percent in the past 52 weeks. Sequenom commands market capitalization of $469.81 million. The stock is likely to go up to $4.18 price level in the coming trading sessions. Sign up for the free technical analysis on SQNM at

http://www.StockCall.com/SQNM041213.pdf

Peregrine Pharmaceuticals closed Thursday's session at $1.37, down 0.72 percent. The stock is currently in the neutral mode and may touch $1.29 level in the coming days. Upon breaching this level, the stock's next support price is at $1.21. Peregrine's stock is mildly volatile with its beta at 0.91. So far in 2013, the stock appreciated 11.38 percent. Its 52 weeks gain stands at 180.34 percent. The stock has traded in the range of $0.39 and $5.50 during the said time period. The company commands market capitalization of $187.84 million. Download the free report on PPHM by registering at

http://www.StockCall.com/PPHM041213.pdf

Inovio Pharmaceuticals Inc. trimmed its 52-weeks loss by closing 2.81 percent higher. The stock ended yesterday's session at $0.586, while its highest price point for the session stood at $0.59. It traded 2.12 million shares, down from its average daily volume of 2.23 million. Inovio traded in the range of $0.38 and $0.83 in the past 52 weeks and commands market capitalization of $106.16 million. The company reported its latest EPS at -$0.15. Stocks of INO lost more than 12 percent in the past 52 weeks. It is highly volatile with beta of 2.81. The free report on INO can be downloaded by signing up now at

http://www.StockCall.com/INO041213.pdf

Onyx Pharmaceuticals Inc. closed its latest trading session at $97.07, up 2.87 percent from its previous close. The stock traded in the range of $94.51 and $99.40 in the session and traded 1.93 million shares. It is likely to face its first resistance level at $97.55 and upon breaching this level the stock may go up to $97.96. On the downside, Onyx Pharmaceuticals may tumble to $93.05 level. The stock is volatile as it sports the beta of 1.15. So far in 2013, it gained 28.33 percent whereas in the past 52 weeks, it gained 133.96 percent of its value. The stock is in a bullish mode. Free report on ONXX can be accessed by registering at

http://www.StockCall.com/ONXX041213.pdf

About StockCall.com

StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at

http://www.stockcall.com

SOURCE StockCall.com